Evidence map›Paper›PMID 31808251›Full record

ArticleAngewandte Chemie (International ed. in English)2020

Selective and Wash-Resistant Fluorescent Dihydrocodeinone Derivatives Allow Single-Molecule Imaging of μ-Opioid Receptor Dimerization.

Christian Gentzsch, Kerstin Seier, Antonios Drakopoulos, Marie-Lise Jobin, Yann Lanoiselée, Zsombor Koszegi, Damien Maurel, Rémy Sounier, Harald Hübner, Peter Gmeiner and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Local GPCR density tips the balance of μ-opioid receptor trafficking.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Photo-affinity and Metabolic Labeling Probes Based on the Opioid Alkaloids.Chembiochem : a European journal of chemical biology · 2024
    Article
  8. Chemical tools for the opioids.Molecular and cellular neurosciences · 2023
    Review
  9. Article
  10. Photochromic Fentanyl Derivatives for Controlled μ-Opioid Receptor Activation.Chemistry (Weinheim an der Bergstrasse, Germany) · 2022
    Article
  11. Opioid Pharmacology under the Microscope.Molecular pharmacology · 2020
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Christian GentzschPharmaceutical and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry, Julius Maximilian University of Würzburg, Am Hubland, 97074, Würzburg, Germany.ORCID 0000-0003-3885-1081
Kerstin SeierInstitute of Pharmacology and Toxicology, Julius Maximilian University of Würzburg, Versbacher Strasse 9, 97078, Würzburg, Germany.ORCID 0000-0002-6027-7859
Antonios DrakopoulosPharmaceutical and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry, Julius Maximilian University of Würzburg, Am Hubland, 97074, Würzburg, Germany.ORCID 0000-0001-9178-7213
Marie-Lise JobinInstitute of Pharmacology and Toxicology, Julius Maximilian University of Würzburg, Versbacher Strasse 9, 97078, Würzburg, Germany.
Yann LanoiseléeInstitute of Metabolism and Systems Research & Centre of Membrane Proteins and Receptors, University of Birmingham, IBR Tower, Level 2, Edgbaston, Birmingham, B152TT, UK.ORCID 0000-0003-3116-9362
Zsombor KoszegiInstitute of Metabolism and Systems Research & Centre of Membrane Proteins and Receptors, University of Birmingham, IBR Tower, Level 2, Edgbaston, Birmingham, B152TT, UK.ORCID 0000-0003-2192-0159
Damien MaurelARPEGE (Pharmacology Screening Interactome) platform facility, Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, 141, rue de la Cardonille, 34094, Montpellier Cedex 05, France.
Rémy SounierInstitut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, 141, rue de la Cardonille, 34094, Montpellier Cedex 05, France.ORCID 0000-0002-7802-2838
Harald HübnerMedicinal Chemistry, Department of Chemistry and Pharmacy, Friedrich-Alexander University of Erlangen-Nuremberg, 91058, Erlangen, Germany.
Peter GmeinerMedicinal Chemistry, Department of Chemistry and Pharmacy, Friedrich-Alexander University of Erlangen-Nuremberg, 91058, Erlangen, Germany.
Sébastien GranierInstitut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, 141, rue de la Cardonille, 34094, Montpellier Cedex 05, France.
Davide CalebiroInstitute of Pharmacology and Toxicology, Julius Maximilian University of Würzburg, Versbacher Strasse 9, 97078, Würzburg, Germany.
Michael DeckerPharmaceutical and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry, Julius Maximilian University of Würzburg, Am Hubland, 97074, Würzburg, Germany.ORCID 0000-0002-6773-6245
University of Würzburg · DECentre National de la Recherche Scientifique · FRFriedrich-Alexander-Universität Erlangen-Nürnberg · DEUniversity of Birmingham · GB

Funding

Structural Basis of Opioid Receptor FunctionR37DA036246 · NIDA · STANFORD UNIVERSITY · PI KOBILKA, BRIAN K · 2013 to 2020
$4.2M
The structural basis for pathway-selective signaling by the µ opioid receptorR01DA036246 · NIDA · STANFORD UNIVERSITY · PI Brian K Kobilka · 2024 to 2026
$1.6M
NIDA NIH HHS R01 DA036246NIDA NIH HHS R37 DA036246Wellcome Trust 212313/Z/18/Z
6 · The paper itself

Abstract

μ-Opioid receptors (μ-ORs) play a critical role in the modulation of pain and mediate the effects of the most powerful analgesic drugs. Despite extensive efforts, it remains insufficiently understood how μ-ORs produce specific effects in living cells. We developed new fluorescent ligands based on the μ-OR antagonist E-p-nitrocinnamoylamino-dihydrocodeinone (CACO), that display high affinity, long residence time and pronounced selectivity. Using these ligands, we achieved single-molecule imaging of μ-ORs on the surface of living cells at physiological expression levels. Our results reveal a high heterogeneity in the diffusion of μ-ORs, with a relevant immobile fraction. Using a pair of fluorescent ligands of different color, we provide evidence that μ-ORs interact with each other to form short-lived homodimers on the plasma membrane. This approach provides a new strategy to investigate μ-OR pharmacology at single-molecule level.

Indexed as

Protein MultimerizationDiffusionFluorescent DyesHydrocodoneLigandsProtein Structure, QuaternaryReceptors, Opioid, muSingle Molecule ImagingFluorescent DyesHydrocodoneLigandsReceptors, Opioid, mufluorescent probesG-protein coupled receptorhomodimerizationopioid ligandssingle-molecule microscopy

Identifiers

PMID31808251
PMCPMC7125027
OpenAlexW2992797808

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.